These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1350733)

  • 1. Rilmenidine: a novel approach to first-line treatment of hypertension.
    Laurent S; Safar M
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):99S-105S. PubMed ID: 1350733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
    Harron DW
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on rilmenidine: clinical benefits.
    Reid JL
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):322S-324S. PubMed ID: 11721891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
    Scemama M; Février B; Beucler I; Dairou F
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol.
    Reid JL; Panfilov V; MacPhee G; Elliott HL
    Ann N Y Acad Sci; 1995 Jul; 763():673-8. PubMed ID: 7677387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
    Fletcher AE; Beevers DG; Dollery CT; Wilkinson R; Bulpitt CJ
    Eur J Clin Pharmacol; 1991; 41(5):397-400. PubMed ID: 1684749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and acceptability of rilmenidine in mild to moderate arterial hypertension. A multicenter, randomized, double-blind trial, in comparison with methyldopa in 157 patients].
    Wilkinson R; Mansy S; Corcoran C
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():31-8. PubMed ID: 2517007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and tolerance of rilmenidine in patients with mild to moderate hypertension. Results of a Czech and Slovak 6-month multicenter study].
    Widimský J
    Vnitr Lek; 2002 Aug; 48(8):724-9. PubMed ID: 12425202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
    Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
    Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central I1-imidazoline receptors as targets of centrally acting antihypertensive drugs. Clinical pharmacology of moxonidine and rilmenidine.
    Van Zwieten PA; Peters SL
    Ann N Y Acad Sci; 1999 Jun; 881():420-9. PubMed ID: 10415946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy and acceptability of rilmenidine in elderly hypertensive patients.
    Galley P; Manciet G; Hessel JL; Michel JP
    Am J Cardiol; 1988 Feb; 61(7):86D-90D. PubMed ID: 2894166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rilmenidine for arterial hypertension.
    Beau B; Mahieux F; Paraire M; Laurin S; Brisgand B; Vitou P
    Am J Cardiol; 1988 Feb; 61(7):95D-102D. PubMed ID: 2894168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effort blood pressure control in the course of antihypertensive treatment.
    de Divitiis O; Di Somma S; Liguori V; Petitto M; Magnotta C; Ausiello M; Natale N; Brignoli M; Galderisi M
    Am J Med; 1989 Sep; 87(3C):46S-56S. PubMed ID: 2782327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
    Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
    Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally acting imidazoline I1-receptor agonists: do they have a place in the management of hypertension?
    van Zwieten PA
    Am J Cardiovasc Drugs; 2001; 1(5):321-6. PubMed ID: 14728014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and acceptability of rilmenidine for mild to moderate systemic hypertension.
    Ostermann G; Brisgand B; Schmitt J; Fillastre JP
    Am J Cardiol; 1988 Feb; 61(7):76D-80D. PubMed ID: 2894164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.